Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10180491 | 0.94 | STAT3 (0.47) | STAT3MLNR | |
| SCHEMBL10180492 | 0.94 | STAT3 (0.47) | STAT3MLNR | |
| Bromide SCHEMBL3059647 | 0.86 | STAT3 (0.52) | STAT3 | |
| SCHEMBL3045913 | 0.86 | STAT3 (0.56) | STAT3 | |
| SCHEMBL3045917 | 0.86 | STAT3 (0.56) | STAT3 | |
| SCHEMBL3065118 | 0.85 | STAT3 (0.55) | STAT3 | |
| SCHEMBL10181171 | 0.85 | STAT3 (0.51) | STAT3 | |
| SCHEMBL10180672 | 0.84 | STAT3 (0.57) | STAT3 | |
| Hydrochloric Acid SCHEMBL3051249 | 0.84 | STAT3 (0.50) | STAT3 | |
| Bromide SCHEMBL3056336 | 0.84 | STAT3 (0.56) | STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8551999-B2 | Heterocyclic compound and pharmaceutical composition thereof | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-10-08 | — | — | US | disclosed |
| US-20100261720-A1 | HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100261720-A1 | HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF | COL1A1, COL2A1, COL14A1 | STAT3 1499/4885MLNR 3041/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.